REFERENCES
- Luo XJ, Peng J, et al. Recent advances in the study on capsaicinoids and capsinoids. Eur J of Pharmacol. 2011;650:1–7.
- Jones VM, Moore KA, Capsaicin 8% Topical Patch (Qutenza®)–A Review of the Evidence. J Pain Palliat Care Pharmacother. 2011;25:32–41.
- Honore, P, Chandran, P, Hernandez, G, Gauvin, DM, Mikusa, JP, Zhong, C, Joshi, SK, Ghilardi, JR, Sevcik, MA, Fryer, RM, Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia. Pain. 2009;142:27–35.
REFERENCES
- Noto C, Pappagallo M, Szallasi A. NGX-4010, a high-concentration capsaicin dermal patch for lasting relief of peripheral neuropathic pain. Curr Opin Invest Drugs. 2009;10: 702–710.
- Backonja M, Wallace MS, Blonsky ER, Cutler BJ, Malan PJr, Rauck R, Tobias J, NGX-4010 C116 Study Group. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol. 2008;7:1106–1112.
- Simpson DM, Brown S, Tobias J, NGX-4010 Study Group. Controlled trial of high concentration capsaicin patch for the treatment of painful HIV neuropathy. Neurology. 2008;70:2305–2313.
REFERENCES
- Wincent A, Lidén Y, Pain questionnaires in the analysis of long lasting (chronic) pain conditions. Eur J Pain. 2003;7:311–321.
- Kehlet H, Jensen TS, Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367:1618–1625.
- Backonja M, Wallace MS, Blonsky ER, Cutler BJ, Malan PJr, Rauck R, Tobias J. NGX-4010 C116 Study Group Ref 4- Capsaicin dermal patch: in non-diabetic peripheral neuropathic pain. Lancet Neurol. 2008;7:1106–1112.
- McCormack PL. Capsaicin dermal patch: in nondiabetic peripheral neuropathic pain. Drugs. 2010;70:1831–1842.